All stock reports

EXIDEIND evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-07T23:40:12.406204+00:00

Metrics

latest_annual_period
2026-03-31
revenue
179953500000.0
net_income
8541900000.0
operating_cash_flow
23504500000.0
free_cash_flow
11978200000.0
total_assets
212198800000.0
total_liabilities
72886600000.0
total_equity
139048500000.0
cash
2578100000.0
total_debt
15754000000.0
revenue_growth
0.04394399533584514
earnings_growth
0.07442580060878967
net_margin
0.04746726237611383
roe
0.06143108339895792
debt_to_equity
0.11329859725203796
cash_conversion
2.7516711738606165
free_cash_flow_margin
0.06656275093287989
trailing_pe
44.2077
forward_pe
16.0
peg_ratio
Not supplied
price_to_book
2.9954
dividend_yield
0.0

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Research only. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-39ee947a4b59463f8093fa0102b058477ab0da96ff54607dab7435b5141bc347
Policy
stock-decisions-v1
Evidence bundle hash
c50b00bc6fe099c3fbaf5b112b9a28799bed5770d0f524d202c97b926744ffcd
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 05551098e3a6100f0ce50fb8fae1651b8ccadad4502e6ce17eca149bd8d09124
  • daily-price: 051b79dffcf80d3750fccf40b2d1accbe8eb69231de7510fa8d103a21498931c
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

The cached financial metric revenue growth is 0.04394399533584514. The cached financial metric net margin is 0.04746726237611383. The cached financial metric roe is 0.06143108339895792. The cached financial metric debt to equity is 0.11329859725203796. The cached financial metric cash conversion is 2.7516711738606165. The cached financial metric free cash flow margin is 0.06656275093287989.

Risks

The trailing 5-session price return was -4.01%. The trailing 20-session price return was -3.81%. The trailing 60-session price return was -2.82%. The closing price was -16.55% below its highest close in the available trailing year. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

Price source verification: REPAIRED. Average cached traded value over twenty sessions was INR 896,335,428. Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-07T23:40:12.406204+00:00 from EODHD. The cached financial metric latest annual period is 2026-03-31.

Cached observations and evidence limits